Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: A meta-analysis with an indirect comparison of randomised trials

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 110, Issue 12, 2003, Pages 1045-1049

  Coomarasamy, Aravinthan ^a   Knox, Ellen M ^b   Gee, Harry ^a   Song, Fujian ^c   Khan, Khalid S ^a  

^a BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

^b MANOR HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; NIFEDIPINE;

ANALYTIC METHOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; META ANALYSIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REDUCTION; REVIEW; STATISTICAL ANALYSIS; TOCOLYSIS;

ADRENERGIC BETA-AGONISTS; FEMALE; HUMANS; NIFEDIPINE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RANDOMIZED CONTROLLED TRIALS; TOCOLYSIS; TOCOLYTIC AGENTS; TREATMENT OUTCOME; VASOTOCIN;

EID: 0345096652     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2003.03071.x     Document Type: Review

References (34)

1. Beta-agonists for the care of women in preterm labour. RCOG (Royal College of Obstetricians and Gynaecologists, UK) Guideline No 1A. London, RCOG, 1997.
2. King J.F., Grant A., Keirse M.J., Chalmers I. Beta-mimetics in preterm labour: an overview of the randomized controlled trials. Br J Obstet Gynaecol. 95:1988;211-222.
3. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. The Canadian Preterm Labor Investigators Group. N Engl J Med. 327:1992;308-312.
4. Duley LM. Tocolytic drugs for women in preterm labour. RCOG (Royal College of Obstetricians and Gynaecologists, UK) Guideline No 1B. London, RCOG, 2002.
5. Tsatsaris V., Papatsonis D., Goffinet F., Dekker G., Carbonne B. Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis. Obstet Gynecol. 97:2001;840-847.
6. Coomarasamy A., Knox E.M., Gee H., Khan K.S. Oxytocin antagonists for tocolysis in preterm labour - a systematic review. Med Sci Monit. 8:2002;RA268-RA273.
7. Song F., Glenny A.M., Altman D.G. Indirect comparison in evaluating relative efficacy illustrated by antimicrobial prophylaxis in colorectal surgery. Control Clin Trials. 21:2000;488-497.
8. Bucher H.C., Guyatt G.H., Griffith L.E., Walter S.D. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 50:1997;683-691.
9. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials. 7:1986;177-188.
10. Song F., Altman D.G., Glenny A.M., Deeks J.J. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ. 326:2003;472.
11. Read M.D., Wellby D.E. The use of a calcium antagonist (nifedipine) to suppress preterm labour. Br J Obstet Gynaecol. 93:1986;933-937.
12. Janky E., Leng J.J., Cormier P.H., Salamon R., Meynard J. A randomized study of the treatment of threatened premature labor. Nifedipine versus ritodrine. J Gynecol Obstet Biol Reprod (Paris). 19:1990;478-482.
13. Ferguson J.E., Dyson D.C., Schutz T., Stevenson D.K. A comparison of tocolysis with nifedipine or ritodrine: analysis of efficacy and maternal, fetal, and neonatal outcome. Am J Obstet Gynecol. 163:1990;105-111.
14. Bracero L.A., Leikin E., Kirshenbaum N., Tejani N. Comparison of nifedipine and ritodrine for the treatment of preterm labor. Am J Perinatol. 8:1991;365-369.
15. Smith C.S., Woodland M.B. Clinical comparison of oral nifedipine and subcutaneous terbutaline for initial tocolysis. Am J Perinatol. 10:1993;280-284.
16. Kupferminc M., Lessing J.B., Yaron Y., Peyser M.R. Nifedipine versus ritodrine for suppression of preterm labour. Br J Obstet Gynaecol. 100:1993;1090-1094.
17. Papatsonis D.N., Van Geijn H.P., Ader H.J., Lange F.M., Bleker O.P., Dekker G.A. Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet Gynecol. 90:1997;230-234.
18. Koks C.A., Brolmann H.A., de Kleine M.J., Manger P.A. A randomized comparison of nifedipine and ritodrine for suppression of preterm labor. Eur J Obstet Gynecol Reprod Biol. 77:1998;171-176.
19. Garcia-Velasco J.A., Gonzalez G.A. A prospective, randomized trial of nifedipine vs. ritodrine in threatened preterm labor. Int J Gynaecol Obstet. 61:1998;239-244.
20. Moutquin J.M., Sherman D., Cohen Het al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am J Obstet Gynecol. 182:2000;1191-1199.
21. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study. Acta Obstet Gynecol Scand. 80(5):2001;413-422.
22. Goodwin T.M., Valenzuela G.J., Silver H., Creasy G. Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group. Obstet Gynecol. 88:1996;331-336.
23. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. Eur J Obstet Gynecol Reprod Biol. 98:2001;177-185.
24. Chalmers T.C., Smith H. Jr., Blackburn Bet al. A method for assessing the quality of a randomized control trial. Control Clin Trials. 2:1981;31-49.
25. Dickersin K., Berlin J.A. Meta-analysis: state-of-the-science. Epidemiol Rev. 14:1992;154-176.
26. Crowley P. Corticosteroids prior to preterm delivery [Cochrane review]. The Cochrane Library, Issue 3. Oxford: Update Software, 1998.
27. Sterne J.A., Davey S.G. Sifting the evidence - what's wrong with significance tests? BMJ. 322:2001;226-231.
28. Rich S., Kaufmann E., Levy P.S. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med. 327:1992;76-81.
29. King JF, Flenady VJ, Papatsonis DN, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev 2003;CD002255.
30. Schulz K.F., Chalmers I., Hayes R.J., Altman D.G. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 273:1995;408-412.
31. Blea C.W., Barnard J.M., Magness R.R., Phernetton T.M., Hendricks S.K. Effect of nifedipine on fetal and maternal hemodynamics and blood gases in the pregnant ewe. Am J Obstet Gynecol. 176:1997;922-930.
32. Ernst E., Pittler M.H. Assessment of therapeutic safety in systematic reviews: literature review. BMJ. 323:2001;546.
33. Goodwin T.M., Paul R., Silver Het al. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human. Am J Obstet Gynecol. 170:1994;474-478.
34. Romero R., Sibai B.M., Sanchez-Ramos Let al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol. 182:2000;1173-1183.